Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules

Nature Communications

Volumn 1, Issue 6, 2010, Pages

  Galloway, Warren R J D ^a   Isidro Llobet, Albert ^a   Spring, David R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; EMMACIN; ERYTHROMYCIN; GEMMACIN; GEMMACIN B; NATURAL PRODUCT; OXACILLIN; ROBOTNIKIN; UNCLASSIFIED DRUG;

BIODIVERSITY; BIOLOGICAL ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR LIBRARY; REVIEW; VALIDATION STUDY; ARTICLE; CHEMICAL STRUCTURE; COMBINATORIAL CHEMISTRY; DRUG DEVELOPMENT; METHODOLOGY;

COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DISCOVERY; MOLECULAR STRUCTURE; SMALL MOLECULE LIBRARIES;

EID: 84880296641     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1081     Document Type: Review

References (86)

1. Burke M.D.& Schreiber S. L. A planning strategy for diversity-oriented synthesis. A ngew. Chem., Int. Ed. 4 3 46 - 58 ( 2004 ). A seminal introduction to diversity-oriented synthesis (DOS) and a discussion of various planning strategies in DOS. (Pubitemid 38063470)
2. Schreiber S.L. The small-molecule approach to biology. Chem. Eng. News. 8 1 51-61 ( 2003 ).
3. Galloway W. R. J.D. Bender A. Welch M.& Spring D.R. The discovery of antibacterial agents using diversity-oriented synthesis. Chem. Commun.
4. Kaiser M. Wetzel S. Kumar K.& Waldmann H. Biology-inspired synthesis of compound libraries. C ell. Mol. Life. Sci. 6 5 1186-1201 ( 2008 ).
5. Spring D.R. Chemical genetics to chemical genomics: Small molecules offer big insights. Chem. Soc. Rev. 34 472-482 ( 2005 ). (Pubitemid 40880427)
6. Kawasumi M.& Nghiem P. Chemical genetics: Elucidating biological systems with small-molecule compounds. J. Invest. Dermat. 127 1577-1584 ( 2007 ). (Pubitemid 46933419)
7. Spiegel D.A. Schroeder F.C. Duvall J.R.& Schreiber S.L. An oligomerbased approach to skeletal diversity in small-molecule synthesis. J. Am. Chem. Soc. 128 14766-14767 ( 2006 ). (Pubitemid 44851590)
8. Walsh D.P.& Chang Y.T. Chemical genetics. Chem. Rev. 106 2476-2530 ( 2006 ).
9. Galloway W. R. J.D. Diaz-Gavilan M. Isidro-Llobet A.& Spring D.R. Synthesis of unprecedented scaff old diversity. Angew. Chem., Int. Ed. 48 1194-1196 ( 2009 ).
10. Galloway W. R. J.D.& Spring D.R. Is synthesis the main hurdle for the generation of diversity in compound libraries for screening? Exp. Opin. Drug Discov. 4 467-472 ( 2009 ).
11. Tan D.S. Diversity-oriented synthesis: Exploring the intersections between chemistry and biology. Nat. Chem. Biol. 1 74-84 ( 2005 ).
12. Spring D.R. Diversity-oriented synthesis; a challenge for synthetic chemists. Org. Biomol. Chem. 1 3867-3870 ( 2003 ).
13. Haggarty S.J. The principle of complementarity: Chemical versus biological space. Curr. Opin. Chem. Biol. 9 296-303 ( 2005 ). (Pubitemid 40804553)
14. Schawrz M.K.& Sauer W.H.B. Molecular shape diversity of combinatorial libraries: Aprerequisite for broad bioactivity. J. Chem. Inf. Comput. Sci. 43 987 - 1003 ( 2003 ). An excellent discussion of the relationship between molecular shape (scaff old) diversity and functional diversity in small molecule libraries.
15. Kennedy J.P. et al. Application of combinatorial chemistry science on modern drug discovery.J. Comb. Chem. 1 0 345-354 ( 2008 ).
16. Le G.T. e t al. Molecular diversity through sugar scaff olds. Drug Discov. Today 8 701-709 ( 2003 ).
17. Th omas G.L. Wyatt E.E.& Spring D.R. Enriching chemical space with diversity-oriented synthesis. Curr. Opin. Drug Discov. Deve. 9 700-712 ( 2006 ). (Pubitemid 44759564)
18. Spandl R.J. Bender A.& Spring D.R. Diversity-oriented synthesis; a spectrum of approaches and results. Org. Biomol. Chem. 6 1149-1158 ( 2008 ). (Pubitemid 351432832)
19. Burke M.D. Berger E. M.& Schreiber S. L. Generating diverse skeletons of small molecules combinatorially. Science 302 613-618 ( 2003 ). (Pubitemid 37310911)
20. Haigh J.A. Pickup B.T. Grant J.A.& Nicholls A. S mall molecule shapefi ngerprints. J. Chem. Inform. Model. 4 5 673-684 ( 2005 ).
21. Shelat A.A.& Guy R.K. Scaff old composition and biological relevance of screening libraries. N at. Chem. Biol. 3 442-446 ( 2007 ). (Pubitemid 47080378)
22. Lovering F. Bikker J.& Humblet C. Escape from Flatland: Increasing saturation as an approach to improving clinical success.J. Med. Chem. 5 2 6752-6756 ( 2009 ).
23. Lipinski C.& Hopkins A. Navigating chemical space for biology and medicine. N ature 432 855 - 861 ( 2004 ). A useful discussion of the concepts of total chemical space and biologically relevant chemical space. (Pubitemid 40037141)
24. Bender A. et al. Diversity Oriented Synthesis: A Challenge for Synthetic Chemists. Ernst Schering Research Foundation Workshop 58, 47-60 ( Springer ) 2006.
25. Hopkins A.L. Mason J.S.& Overington J.P. Can we rationally design promiscuous drugs? Curr. Opin. Struct. Biol. 16 127-136 ( 2006 ). (Pubitemid 43221881)
26. Newman D.J.& Cragg G. M. Natural products as sources of new drugs over the last 25 years. J Nat. Prod. 70 461-477 ( 2007 ). (Pubitemid 46595760)
27. von Nussbaum F. Brands M. Hinzen B. Weigand S.& Habich D. Antibacterial natural products in medicinal chemistry - Exodus or revival? Angew. Chem., Int. Ed. 4 5 5072-5129 ( 2006 ).
28. Schneider G.& Grabowski K. Properties and architecture of drugs and natural products revisited. Curr. Chem. Biol. 1 115-127 ( 2007 ).
29. Schreiber S.L. Molecular diversity by design. Nature 4 57 153 - 154 ( 2009 ). An interesting discussion of the limitations of ? traditional ? small molecule collections and how these can be addressed using diversity-driven synthetic approaches such as DOS.
30. Nielsen T. E.& Schreiber S. L. Diversity-oriented synthesis- Towards the optimal screening collection: Asynthesis strategy. A ngew. Chem., Int. Ed. 4 7 48 - 56 ( 2008 ). A useful introduction to the build-couple-pair strategy, a common strategic feature in many DOS pathways.
31. Drews J. What's in a number? N at. Rev. Drug Discov. 5 975 ( 2006 ). (Pubitemid 44835123)
32. Strosberg A.D. Breaking the spell: Drug discovery based on modulating protein-protein interactions. E xpert Rev. Proteomics 1 141-143 ( 2004 ).
33. Schreiber S.L. The state of the art of chemical biology. Chem. Biol. Chem. 1 0 26-29 ( 2009 ).
34. Pizzirani D. Kaya T. Clemons P. A.& Schreiber S. L. Stereochemical and skeletal diversity arising from amino propargylic alcohols. Org. Lett. 1 2 2822 - 2825 ( 2010 ).
35. Dandapani S.& Marcaurelle L.A. Current strategies for diversity-oriented synthesis. Curr. Opin. Chem. Biol. 14 362 - 370 ( 2010 ).
36. Payne D.J. Gwynn M.N. Holmes D.J.& Pompliano D.L. Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6 29-40 ( 2007 ). (Pubitemid 46020284)
37. Taylor A.M.& Schreiber S.L. Aziridines as intermediates in diversity-oriented syntheses of alkaloids. Tet. Lett. 5 0 3230-3233 ( 2009 ).
38. Noren-Muller A. et al. Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. P roc. Natl Acad. Sci. USA 103 10606-10611 ( 2006 ). (Pubitemid 44078024)
39. DeSimone R.W. Currie K.S. Mitchell S.A. Darrow J.W.& Pippin D.A. Privileged structures: Applications in drug discovery. Comb. Chem. High Th roughput Screening 7 473-493 ( 2004 ). (Pubitemid 39108267)
40. Danishefsky S. On the potential of natural products in the discovery of pharma leads: A case for reassessment. Nat. Prod. Rep. 27 1114-1116.
41. Koch M.A. et al. Charting biologically relevant chemical space: Astructural classifi cation of natural products (SCONP). Proc. Natl Acad. Sci. USA 1 02 17272-17277 ( 2005 ). (Pubitemid 41740856)
42. Lipkus A.H. e t al. Structural diversity of organic chemistry. A scaff old analysis of the CAS Registry. J. Org. Chem. 73 4443-4451 ( 2008 ). (Pubitemid 351842458)
43. Lai J. Salunke D.B.& Sun C. Multistep microwave-assisted divergent synthesis of indolo-fused pyrazino-/aiazepinoquinoxalinones on PEG support. O rg. Lett. 1 2 2174 - 2177 ( 2010 ).
44. Burke M.D.& Lalic G. Teaching target-oriented and diversity-oriented organic synthesis at Harvard University. Chem. Biol. 9 535-541 ( 2002 ). (Pubitemid 34593033)
45. Borman S. Rescuing combichem. Chem. Eng. News: Sci. Technol. 82 32-40 ( 2004 ).
46. Mishra J.K.& Panda G. Diversity-oriented synthetic approach to naturally abundant S-amino acid based benzannulated enantiomerically pure medium ring heterocyclic scaff olds employing inter- and intramolecular Mitsunobu reactions. J. Comb. Chem. 9 321-338 ( 2007 ).
47. Taylor S.J. Taylor A. M.& Schreiber S. L. Synthetic strategy toward skeletal diversity via solid-supported, Otherwise unstable reactive intermediates. Angew. Chem., Int. Ed. 4 3 1681-1685 ( 2004 ). (Pubitemid 39257862)
48. Burke M.D. Berger E. M.& Schreiber S. L. A synthesis strategy yielding skeletally diverse small molecules combinatorially. J. Am. Chem. Soc. 1 26 14095-14104 ( 2004 ). (Pubitemid 39447088)
49. Wyatt E.E. et al. Skeletal diversity construction via a branching synthetic strategy. Chem. Commun. 3296-3298 ( 2006 ). (Pubitemid 44167928)
50. Oguri H.& Schreiber S.L. Skeletal diversity via a folding pathway: Synthesis of indole alkaloid-like skeletons. Org. Lett. 7 47-50 ( 2005 ). (Pubitemid 40138308)
51. Rolfe A. Lushington G.H.& Hanson P.R. Reagent based DOS: A' Click, Click, Cyclize ' strategy to probe chemical space. Org. Biomol. Chem. 8 2198-2203.
52. Zhou A. Rayabarapu D.& Hanson P.R. ' Click, click, cyclize ' : ADOS approach to sultams utilizing vinyl sulfonamide linchpins. Org. Lett. 11 531-534 ( 2009 ).
53. Bauer R.A. DiBlasi C.M.& Tan D.S. The tert-butylsulfi namide lynchpin in transition-metal-mediated multiscaff old library synthesis. Org. Lett. 12 2084-2087.
54. Kumagai N. Muncipinto G.& Schreiber S. L. Short synthesis of skeletally and stereochemically diverse small molecules by coupling petasis condensation reactions to cyclization reactions. Angew. Chem., Int. Ed. 45 3635-3638 ( 2006 ). (Pubitemid 44105728)
55. Th omas G.L. e t al. Anti-MRSA agent discovery using diversity-oriented synthesis. A ngew. Chem., Int. Ed. 47 2808-2812 ( 2008 ).
56. Th omas G.L. Ladlow M.& Spring D.R. Complete functionalisation of small and large diameter bromopolystyrene beads; applications for solid-supported reagents, scavengers and diversity-oriented synthesis. Org. Biomol. Chem. 2 1679-1681 ( 2004 ).
57. Morton D. Leach S. Cordier C. Warriner S.& Nelson, A. Synthesis of natural- product-like molecules with over eighty distinct scaff olds. A ngew. Chem., Int. Ed. 4 8 104 - 109 ( 2009 ). Th is work describes the synthesis of a library of compounds based around 84 distinct molecular scaff olds, arguably representing the current state- of-theart for scaff old diversity generated in a synthetic small molecule library.
58. Biggs-Houck J.E. Younai A.& Shaw J.T. Recent advances in multicomponent reactions for diversity-oriented synthesis. Curr. Opin. Chem. Biol. 14 371-382.
59. Fergus S. Bender A.& Spring D.R. Assessment of structural diversity in combinatorial synthesis. Curr. Opin. Chem. Biol. 9 304-309 ( 2005 ). (Pubitemid 40804554)
60. Perez J.J. Managing molecular diversity. Chem. Soc. Rev. 34 143-152 ( 2005 ). (Pubitemid 40311447)
61. Bender A.& Glen R.C. Molecular similarity: A key technique in molecular informatics. Org. Biomol. Chem. 2 3204-3218 ( 2004 ).
62. Ringner M. What is principal component analysis? N at. Biotechnol. 2 6 303-304 ( 2008 ). (Pubitemid 351355122)
63. Wetzel S. e t al. Interactive exploration of chemical space with Scaff old Hunter. Nat. Chem. Biol. 5 581-583 ( 2009 ).
64. Renner S. et al. Bioactivity-guided mapping and navigation of chemical space. Nat. Chem. Biol. 5 585-592 ( 2009 ).
65. Diaz-Gavilan M. Galloway W. R. J.D. O ' Connell, K.M.G. Hodkingson J.T.& Spring D.R. Diversity-oriented synthesis of bicyclic and tricyclic alkaloids. Chem. Commun. 4 6 776 - 778 ( 2010 ).
66. Di Micco S. e t al. Identifi cation of lead compounds as antagonists of protein Bcl-x(L) with a diversity-oriented multidisciplinary approach. J. Med. Chem. 52 7856-7867 ( 2009 ).
67. Kuruvilla F.G. Shamji A.F. Sternson S.M. Hergenrother P.J.& Schreiber S.L. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. N ature 416 653-657 ( 2002 ). (Pubitemid 34406768)
68. Stanton B.Z. et al. A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat. Chem. Biol. 5 154-156 ( 2009 ).
69. Ng P.Y. Tang Y.C. Knosp W.M. Stadler H.S.& Shaw J.T. Synthesis of diverse lactam carhoxamides leading to the discovery of a new transcriptionfactor inhibitor. Angew. Chem., Int. Ed. 4 6 5352-5355 ( 2007 ). (Pubitemid 47067632)
70. Koehler A.N. Shamji A.F.& Schreiber S.L. Discovery of an inhibitor of a transcription factor using small molecule microarrays and diversity-oriented synthesis.J. Am. Chem. Soc. 125 8420-8421 ( 2003 ). (Pubitemid 36858396)
71. Wyatt E.E. et al. Identifi cation of an anti-MRSA dihydrofolate reductase inhibitor from a diversity-oriented synthesis. Chem. Commun. 4962 - 4964 ( 2008 ). The authors report on the mode of action of an inhibitor of MRSA discovered from a diversity-oriented synthesis program.
72. Schreiber S. L. Target-oriented and diversity-oriented organic synthesis in drug discovery. S cience 287 1964-1969 ( 2000 ). (Pubitemid 30158663)
73. Spring D.R. Krishnan S.& Schreiber S. L. Towards diversity-oriented, stereoselective syntheses of Biaryl- or Bis(aryl)metal-containing medium rings. J. Am. Chem. Soc. 1 12 5656-5657 ( 2000 ). (Pubitemid 30431093)
74. Spring D.R. Krishnan S. Blackwell H. E.& Schreiber S. L. Diversity oriented synthesis of biaryl-containing medium rings using a one bead/one stock solution platform. J. Am. Chem. Soc. 124 1354-1363 ( 2002 ). (Pubitemid 34169142)
75. Broad Institute Chemical Biology Platform [ http://www.broadinstitute. org/science/platforms/chemical-biology-platform/chemical-biology-platform ]. Accessed 24 May 2010.
76. Memorial Sloan-Kettering Cancer Center [ http://www.mskcc.org/mskcc/ html/5804.cfm ]. Accessed 24 May 2010.
77. The PubChem Project [ http://pubchem.ncbi.nlm.nih.gov/ ]. Accessed 2 August 2010.
78. The NIH Common Fund Molecular Libraries and Imaging [ http://nihroadmap. nih.gov/molecularlibraries ]. Accessed 24 May 2010.
79. McDonald P.R. e t al. High throughput screening in academia drug discovery initiatives at the University of Kansas [ http://www.ddw-online.com/ screening/239393/high-throughput-screening-in-academia-drug-discovery- initiatives-at-the-university-of-kansas.html ] (2008). Accessed 24 May 2010.
80. Hajduk P.J.& Greer J. A decade of fragment-based drug design: Strategic advances and lessons learned. Nat. Rev. Drug Discov. 6 211-219 ( 2007 ). (Pubitemid 46344625)
81. Fischer M.& Hubbard R.E. Fragment-based ligand discovery. M ol. Interv. 9 22-30 ( 2009 ).
82. Siegal G. Ab E.& Schultz J. Integration of fragment screening and library design. Drug Discov. Today 12 1032-1039 ( 2007 ). (Pubitemid 350180558)
83. Jahnke W& Erlanson D.A. Fragment-Based Approaches in Drug Discovery; Methods and Principles in Medicinal Chemistry Vol. 34 ( Wiley-VCH 2006 ).
84. Robinson A. Th omas G. L. Spandl R.J. Welch M.& Spring D.R. Gemmacin B: Bringing diversity back into focus. Org. Biomol. Chem. 6 2978-2981 ( 2008 ).
85. Moore P.C.& Lindsay J.A. Molecular characterisation of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA- 16.J. Med. Microbiol. 5 1 516-521 ( 2002 ). (Pubitemid 34492981)
86. Johnson A.P. et al. Dominance of EMRSA-15 and -16.J. Antimicrob. Chemother. 4 8 141-156 ( 2001 ).